Cargando…

Efficacy and safety of Shufeng Jiedu capsule for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis

BACKGROUND: From the end of 2019 to the present, coronavirus disease 2019 (COVID-19) has put considerable pressure on the worlds medical system and caused significant mortality and economic losses around the world. In China, the Shufeng Jiedu capsule has been widely used in the treatment of COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Runmin, Li, Ying, Li, Bingchen, Sun, Haiyang, Liu, Xinyu, Ge, Xin, Liu, Yuanxiang, Yang, Jiguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	4900
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593069/ https://www.ncbi.nlm.nih.gov/pubmed/32769921 http://dx.doi.org/10.1097/MD.0000000000021615

Ejemplares similares

Efficacy and safety of Shufeng Jiedu capsule in the treatment of COVID-19: A protocol for systematic review and meta analysis
por: Ma, Li, et al.
Publicado: (2020)

Study on basic and clinical application of Shufeng Jiedu Capsule in treating respiratory tract infection
por: Han, Yanqi, et al.
Publicado: (2023)

Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology
por: Chen, Xiao, et al.
Publicado: (2020)

Efficacy and safety of Tian Meng oral liquid for the treatment of insomnia: A protocol for systematic review and meta-analysis
por: Liu, Xinyu, et al.
Publicado: (2021)

Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools
por: Xiong, Haijun, et al.
Publicado: (2020)

Efficacy and safety of Shufeng Jiedu Capsule in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis
por: Ren, Huijun, et al.
Publicado: (2021)

Effectiveness comparisons of different Chinese herbal injection therapies for acute cerebral infarction: A protocol for systematic review and network meta-analysis
por: Li, Runmin, et al.
Publicado: (2020)

The add-on effect of Shufeng Jiedu capsule for treating COVID-19: A systematic review and meta-analysis
por: Sheng, Xiaodi, et al.
Publicado: (2022)

Shufeng Jiedu capsules for treating acute exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Xia, Ru-yu, et al.
Publicado: (2020)

Shufeng Jiedu capsule for acute exacerbation of chronic obstructive pulmonary disease: a protocol of multicentre, randomised, double-blind, placebo-controlled trial
por: Xia, Ruyu, et al.
Publicado: (2023)

Analysis of the active components and mechanism of Shufeng Jiedu capsule against COVID-19 based on network pharmacology and molecular docking
por: Simayi, Jimilihan, et al.
Publicado: (2022)

Chinese patent herbal medicine (Shufeng Jiedu capsule) for acute upper respiratory tract infections: A systematic review and meta-analysis
por: Zhang, Ying-ying, et al.
Publicado: (2021)

Association between ABO blood groups and risk of coronavirus disease 2019: A protocol for systematic review and meta-analysis
por: Liu, Nanyang, et al.
Publicado: (2020)

Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

A systematic review and meta-analysis of the efficacy and safety of arbidol in the treatment of coronavirus disease 2019
por: Wang, Xuemei, et al.
Publicado: (2020)

The efficacy of colchicine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysis
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2020)

Coronavirus disease 2019 (COVID-19) related cytopenia: A protocol for systematic review and meta-analysis
por: Li, Yiwei, et al.
Publicado: (2020)

Systematic analyses on the potential immune and anti-inflammatory mechanisms of Shufeng Jiedu Capsule against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-caused pneumonia
por: Tao, Zhengang, et al.
Publicado: (2020)

Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI
por: Cai, Junnan, et al.
Publicado: (2022)

Assessment of the efficacy and safety of Ribavirin in treatment of coronavirus-related pneumonia (SARS, MERS and COVID-19): A protocol for systematic review and meta-analysis
por: Wang, Yinhua, et al.
Publicado: (2020)

An infant with coronavirus disease 2019 in China: A case report
por: Cao, Wen, et al.
Publicado: (2020)

Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy
por: Ding, Jiaxing, et al.
Publicado: (2021)

Inflammatory cytokine depletion in severe coronavirus disease 2019 infectious pneumonia: A case report
por: Yang, Bo, et al.
Publicado: (2020)

Clinical characteristics and viral shedding kinetics of 38 asymptomatic patients with coronavirus disease 2019: A retrospective observational study
por: Li, Yanyan, et al.
Publicado: (2020)

The effect of coagulation factors in 2019 novel coronavirus patients: A systematic review and meta-analysis
por: Xiang, Guiling, et al.
Publicado: (2021)

A case report of a pregnant woman infected with coronavirus disease 2019 pneumonia
por: Peng, Jing, et al.
Publicado: (2020)

Xuan Fei Bai Du Fang for treating coronavirus disease 2019: A protocol for systematic review and meta-analysis
por: Cui, Yuying, et al.
Publicado: (2021)

Risk factors for Coronavirus disease 2019 pneumonia after admission outside Wuhan, China
por: Jie, Li Shao, et al.
Publicado: (2020)

Epidemiological and clinical characteristics of 2019 novel coronavirus disease (COVID-19) in Jilin, China: A descriptive study
por: Liu, Han, et al.
Publicado: (2020)

Arbidol combined with the Chinese medicine Lianhuaqingwen capsule versus arbidol alone in the treatment of COVID-19
por: Liu, Lei, et al.
Publicado: (2021)

Coronavirus disease 2019 (COVID-19) pneumonia in a hemodialysis patient: A case report
por: Huang, Luyan, et al.
Publicado: (2020)

Anticoagulation treatment for patients with coronavirus disease 2019 (COVID-19) and its clinical effectiveness in 2020: A meta-analysis study
por: Ge, Jingyi, et al.
Publicado: (2021)

Analysis of dynamic disturbance in blood coagulation function of patients with Coronavirus Disease 2019: A retrospective observational study
por: Chen, Nian, et al.
Publicado: (2020)

Clinical characteristics, treatment, and prognosis of 74 2019 novel coronavirus disease patients in Hefei: A single-center retrospective study
por: Yang, Jiazhao, et al.
Publicado: (2021)

Efficacy and safety of Lianhua Qingwen in the treatment of patients with moderate COVID-19 infection: A protocol for systematic review and meta analysis
por: Liu, Nanyang, et al.
Publicado: (2020)

Efficacy and safety of traditional Chinese medicine combined with routine western medicine for the asymptomatic novel coronavirus disease (COVID–19): A Bayesian network meta-analysis protocol
por: Wang, Jiahao, et al.
Publicado: (2020)

The role of a chest computed tomography severity score in coronavirus disease 2019 pneumonia
por: Salaffi, Fausto, et al.
Publicado: (2020)

The epidemiological characteristics of 2019 novel coronavirus diseases (COVID-19) in Jingmen, Hubei, China
por: Gao, Qijun, et al.
Publicado: (2020)

Association between presence of Bacillus Calmette–Guerin vaccine scar and coronavirus disease 2019
por: Caliskaner Ozturk, Buket, et al.
Publicado: (2022)

Assessment of Chinese medicine for coronavirus-related pneumonia: A protocol for systematic review and meta-analysis
por: Zhu, Yibing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kq5i2t4lpn4lpfa0h5ojlpah70